Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy

Authors

Michael A. Ciliberto, Washington University School of Medicine in St. Louis
Judith L.Z. Weisenberg, Washington University School of Medicine in St. Louis
Michael Wong, Washington University School of Medicine in St. Louis

Journal

Drug, Healthcare and Patient Safety

Publication Date

2012

Volume

4

Issue

1

Inclusive Pages

81-86

Document Type

Open Access Publication

DOI

10.2147/DHPSS28814

Rights and Permissions

Ciliberto MA,Weisenberg JL,Wong M. 2012. Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy. Drug, Healthcare and Patient Safety. 4(1):81-86. http://dx.doi.org/10.2147/DHPSS28814

Recommended Citation

Ciliberto, Michael A.; Weisenberg, Judith L.Z.; and Wong, Michael, "Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy." Drug, Healthcare and Patient Safety. 4, 1. 81-86. (2012).
https://digitalcommons.wustl.edu/open_access_pubs/1172